High Doses of Candesartan Cilexetil on the Reduction of Proteinuria
NCT00242346
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
270
Enrollment
INDUSTRY
Sponsor class
Conditions
Proteinuria
Interventions
DRUG:
candesartan cilexetil
Sponsor
AstraZeneca